Billionaire Paul Singer's Top 12 Long-Term Stock Picks
The world's "most feared investor," Paul Singer, needs no introduction.
Cormedix Inc. (CRMD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Elliott Management Paul Singer | 2,870,632 | $23,252,119 | +86% | 0.13% |
| 2. | First Turn Management Lisa Wheatley | 1,021,421 | $8,273,510 | 1.48% | |
| 3. | D E Shaw D. E. Shaw | 446,414 | $3,615,953 | +40% | 0% |
| 4. | Citadel Investment Group Ken Griffin | 293,637 | $2,378,460 | +132% | 0% |
| 5. | Millennium Management Israel Englander | 178,134 | $1,442,885 | +98% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.99 | 1,500 | 52,011 | 2024-10-31 | Filing | ||
| $3.74 | 13,561 | 352,839 | 2024-03-13 | Filing | ||
| $3.30 | 3,000 | 15,250 | 2023-12-15 | Filing | ||
| $3.45 | 3,000 | 12,250 | 2023-12-14 | Filing | ||
| $4.00 | 1,000 | 4,900 | 2023-11-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.18 | 140,027 | 45,397 | 2024-11-14 | Filing | ||
| $6.92 | 8,000 | Officer | 0 | 2021-05-21 | Filing | |
| $2.00 | 10,000 | Officer | 0 | 2017-02-07 | Filing | |
| $2.23 | 20,000 | Officer, Director | 0 | 2016-10-21 | Filing | |
| $2.21 | 819 | Officer, Director | 0 | 2016-06-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,567,897 | $36,999,965 | 0% | |
| 2. | 3,378,191 | $27,363,347 | 0% | |
| 3. | 1,453,148 | $11,770,499 | 0% | |
| 4. | 1,392,820 | $11,284,215 | 0% | |
| 5. | 511,565 | $4,143,677 | 0% |
News See All
CorMedix Inc. (NASDAQ:CRMD) Q3 2024 Earnings Call Transcript
Operator: Good day and welcome to the CorMedix Inc. Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
CorMedix Inc. (CRMD): A Bull Case Theory
We came across a bullish thesis on CorMedix Inc. (CRMD) on ValueInvesting subreddit page by gamblingPharmaStocks. In this article, we will summarize the bulls’ thesis on CRMD. CorMedix Inc.
CorMedix Inc. (NASDAQ:CRMD) Q2 2024 Earnings Call Transcript
Operator: Good day, and welcome to the CorMedix Inc. Second Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
CorMedix Inc. (NASDAQ:CRMD) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the CorMedix First Quarter 2024 Earnings Conference Call [Operator Instructions]. Today's conference call is being recorded.
CorMedix Inc. (NASDAQ:CRMD) Q4 2023 Earnings Call Transcript
CorMedix Inc. misses on earnings expectations. Reported EPS is $-0.26 EPS, expectations were $-0.21. CorMedix Inc.
CorMedix Inc. (NASDAQ:CRMD) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to CorMedix Third Quarter 2023 Earnings Conference Call. Today's call is being recorded.
CorMedix Inc. (NASDAQ:CRMD) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to CorMedix, Inc. Second Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Billionaire Hedge Funds
